about
Fertility preservation during cancer treatment: clinical guidelinesRecent advances in oocyte and ovarian tissue cryopreservation and transplantationFertility preservation in women with breast cancerGnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulationOvarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries - compilation of 20 years of multicenter experience.Options on fertility preservation in female cancer patients.Principles of cancer treatment: impact on reproduction.Young women's perceptions of fertility-related information and fertility distress before surgery for ovarian cysts.Sex differences in fertility-related information received by young adult cancer survivors.In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.Attitudes towards new assisted reproductive technologies in Sweden: a survey in women 30-39 years of age.Physicians' self-reported practice behaviour regarding fertility-related discussions in paediatric oncology in Sweden.A prospective investigation of perceived stress, infertility-related stress, and cortisol levels in women undergoing in vitro fertilization: influence on embryo quality and clinical pregnancy rate.Safety of fertility preservation in breast cancer patients in a register-based matched cohort study.Weekend-free scheduled IVF/ICSI procedures and single embryo transfer do not reduce live-birth rates in a general infertile population.Fertility preservation medicine: options for young adults and children with cancer.A prospective study of women and girls undergoing fertility preservation due to oncologic and non‐oncologic indications in Sweden – Trends in patients’ choices and benefit of the chosen methods after long‐term follow‐upThe risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based studyFuture fertility in survivors of childhood cancer—examining the impact of cancer treatment on uterus function[Preserved fertility despite disease with a risk of infertility in young age]Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation?Thicker carotid intima layer and thinner media layer in subjects with cardiovascular diseasesMenopausal estrogen therapy counteracts normal aging effects on intima thickness, media thickness and intima/media ratio in carotid and femoral arteriesValidation of in vivo noninvasive high-frequency ultrasonography of the arterial wall layersTwenty years of development in fertility preservation of women and girls and the challenges that remainA global recommendation for restrictive provision of fertility treatments during the COVID-19 pandemicGM-CSF does not rescue poor-quality embryos: secondary analysis of a randomized controlled trialOvarian Follicles Rescued 3 Days after Cyclophosphamide Treatment in Adolescent Mice: An Experimental Study Aiming at Maximizing Methods for Fertility Preservation through In Vitro Follicle CultureNational guidelines and multilingual age-adapted patient brochures and videos as decision aids for fertility preservation (FP) of children and teenagers with cancer-A multidisciplinary effort to improve children's information and access to FP in SweEndometriosis and cumulative live birth rate after fresh and frozen IVF cycles with single embryo transfer in young women: no impact beyond reduced ovarian sensitivity-a case control studyAssisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort studyEndometriosis, the great imitator - a successful case of fertility preservation in a woman receiving sterilizing treatment due to a diagnosis of rectosigmoid carcinomaFertility preservation for young adults, adolescents, and children with cancerAttitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study
P50
Q26823947-B613A855-2D2F-43B5-8421-639193177908Q27015937-D7764A46-2CDE-42D2-BD36-22F5148D46F2Q36115074-118918CF-9316-40F2-9041-54E431109BDEQ36570314-0ECDACD4-0304-4DBE-ABA9-EF897D481BD3Q37456520-6EDA3029-265B-401D-B20B-41C24F61216BQ37955444-1F270DFA-32B8-49DD-8868-487D238F5634Q37972531-A8721788-D670-4A0C-BE95-1CC0AAF218ECQ39368439-CE84DDA5-D043-4F8D-876A-72605B43C851Q39617534-EEA0266F-A247-4E9F-851D-6C62EE242CEEQ39893170-07AF2C57-3AD8-41DF-B4E2-2FC7B144F1B7Q40316253-E0451D9D-E88E-4F9F-A84F-5DACC6806BFFQ47164012-F53FD2E2-10B6-4013-9EB8-19AB254A1B0FQ47293327-553775E4-A9D8-4111-BB8A-E4AD3D3B240AQ47664870-8F6A967A-8AE1-47DD-94B9-DB199060F6FCQ47757356-350BC7FA-EC95-47C9-8437-90954E0350EAQ48697996-1398941D-52AE-47BE-A138-150D054EC101Q61851248-FC4D768C-2C6D-4F2A-9137-BB2497E58286Q61851249-5ECFC544-4F1B-4F09-8E5F-DB0B3F63AEE9Q61852539-566E3C02-08C6-4825-B5B8-21B67FF812E0Q61852550-8D56A51A-7DBF-4B78-A32C-54B443AA098BQ61852555-8D807AF6-AEB6-403A-9058-0E6EDD55FBA6Q61852558-6740CB3E-697B-4DBD-8BB2-3B57F8F4861EQ61852560-C12B86D7-01A1-40DD-83BE-CCF4FB1714EAQ61852562-85B30741-A20B-4F59-AA7A-73E1A7594E76Q90010284-03C773C2-F719-4FF2-B4C4-71093851B386Q91749022-79D0968F-696E-4D14-8177-9E3F04DCF99EQ91797551-DC09090F-7437-48E1-84E5-9E4423ACD245Q91816745-B60A6304-DDD0-432B-968B-5E0F67E6A1F1Q91821644-1DD2536A-DA3C-43C1-A8EF-2D8B89CE55EEQ91945703-9357AC42-89FD-45DE-A9E0-EC96B035EAD0Q92391420-C8FC4619-ED46-4CF8-ADCC-3424BDD22258Q93082913-B9A3348D-1BC3-4476-BCA5-52B7DC6A1023Q94477783-D85E591D-0207-408E-94C4-05D192FAA7EAQ96231745-EFD9344D-739E-42C0-BD12-0DB5C134269D
P50
description
researcher ORCID ID = 0000-0003-4378-6181
@en
wetenschapper
@nl
name
Kenny A Rodriguez-Wallberg
@ast
Kenny A Rodriguez-Wallberg
@en
Kenny A Rodriguez-Wallberg
@nl
type
label
Kenny A Rodriguez-Wallberg
@ast
Kenny A Rodriguez-Wallberg
@en
Kenny A Rodriguez-Wallberg
@nl
prefLabel
Kenny A Rodriguez-Wallberg
@ast
Kenny A Rodriguez-Wallberg
@en
Kenny A Rodriguez-Wallberg
@nl
P21
P31
P496
0000-0003-4378-6181